Prosecution Insights
Prosecution Insights
36 pending office actions • 27 art units • 36 examiners • 0 of 36 (0%) have an AI response strategy ready • 37 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 36 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 36 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 19 (53%) |
| §102 only | 1 (3%) |
| §112 only | 5 (14%) |
| No statute on record | 11 (31%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KHATTAR, RAJESH | 1 | 36.2% | +35.2% |
| ABDULLAH, AAISHA | 1 | 26.7% | +43.8% |
| HAUK TEODORO, PRICILA NMN | 1 | 100.0% | +0.0% |
| GANGLE, BRIAN J | 1 | 76.4% | +15.4% |
| FOLEY, SHANON A | 1 | 73.7% | +18.1% |
| KLINKEL, KORTNEY L | 1 | 39.5% | +44.6% |
| O DELL, DAVID K | 1 | 57.8% | +35.8% |
| ANDERSON, REBECCA L | 1 | 73.2% | +24.0% |
| SMITH, ADAM MICHAEL | 1 | — | — |
| LEESER, ERICH A | 1 | 81.6% | +13.5% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18549158 | Treatment of Breast Cancer with Amcenestrant and Palbociclib | LEESER, ERICH A | 22d |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18722420 | WEARABLE COMPANION FOR DETECTING THE CYTOKINE RELEASE SYNDROME | ABDULLAH, AAISHA | 112d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18722420 | WEARABLE COMPANION FOR DETECTING THE CYTOKINE RELEASE SYNDROME | ABDULLAH, AAISHA | 112d overdue |
| 18552453 | Ether-Linked Antiviral Compounds | ANDERSON, REBECCA L | 71d overdue |
| 18488191 | COMPOUND FOR THE TREATMENT OF CANCER | KLINKEL, KORTNEY L | 56d overdue |
| 18555058 | COMBINATION THERAPY COMPRISING A PKC INHIBITOR AND A MEK INHIBITOR | O DELL, DAVID K | 5d |
| 18557987 | VACCINATION AGAINST BACTERIAL AND BETACORONAVIRUS INFECTIONS | FOLEY, SHANON A | 8d |
| 18754913 | HEALTH INFORMATION PLATFORM | KHATTAR, RAJESH | 13d |
| 18549158 | Treatment of Breast Cancer with Amcenestrant and Palbociclib | LEESER, ERICH A | 22d |
| 18562387 | RECOMBINANT EXPRESSION OF KLEBSIELLA PNEUMONIAE O-ANTIGENS IN ESCHERICHIA COLI | GANGLE, BRIAN J | 43d |
| Art Unit | Apps |
|---|---|
| 1645 | 5 |
| 1653 | 2 |
| 1637 | 2 |
| 1672 | 2 |
| 1646 | 2 |
| 1624 | 2 |
| 3684 | 1 |
| 3681 | 1 |
| 1671 | 1 |
| 1627 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18754913 | HEALTH INFORMATION PLATFORM | KHATTAR, RAJESH | 3684 | §103 | Final Rejection | 13d | Pending | Jun 26, 2024 |
| 18722420 | WEARABLE COMPANION FOR DETECTING THE CYTOKINE RELEASE SYNDROME | ABDULLAH, AAISHA | 3681 | §103 | Non-Final OA | 112d overdue | Pending | Jun 20, 2024 |
| 18535116 | IMMUNOGENIC COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE AGAINST CLOSTRIDIOIDES (CLOSTRIDIUM) DIFFICILE | HAUK TEODORO, PRICILA NMN | 1645 | Other | Non-Final OA | 34d | Pending | Dec 11, 2023 |
| 18562387 | RECOMBINANT EXPRESSION OF KLEBSIELLA PNEUMONIAE O-ANTIGENS IN ESCHERICHIA COLI | GANGLE, BRIAN J | 1645 | §102 | Non-Final OA | 43d | Pending | Nov 20, 2023 |
| 18557987 | VACCINATION AGAINST BACTERIAL AND BETACORONAVIRUS INFECTIONS | FOLEY, SHANON A | 1671 | §103 | Non-Final OA | 8d | Pending | Oct 30, 2023 |
| 18488191 | COMPOUND FOR THE TREATMENT OF CANCER | KLINKEL, KORTNEY L | 1627 | §112 | Non-Final OA | 56d overdue | Pending | Oct 17, 2023 |
| 18555058 | COMBINATION THERAPY COMPRISING A PKC INHIBITOR AND A MEK INHIBITOR | O DELL, DAVID K | 1621 | §103 | Non-Final OA | 5d | Pending | Oct 12, 2023 |
| 18552453 | Ether-Linked Antiviral Compounds | ANDERSON, REBECCA L | 1626 | §112 | Non-Final OA | 71d overdue | Pending | Sep 26, 2023 |
| 18551038 | PHARMACEUTICAL COMPOSITIONS CONTAINING ADENO-ASSOCIATED VIRAL VECTOR | SMITH, ADAM MICHAEL | 1638 | Other | Non-Final OA | 9d | Pending | Sep 18, 2023 |
| 18549158 | Treatment of Breast Cancer with Amcenestrant and Palbociclib | LEESER, ERICH A | 1622 | §103 | Non-Final OA | 22d | Pending | Sep 05, 2023 |
| 18459381 | CELL CULTURE PROCESS | NGUYEN, NGHI V | 1653 | §103 | Non-Final OA | 14d | Pending | Aug 31, 2023 |
| 18275634 | Methods of Protecting RNA | MCKILLOP, JOHN CHARLES | 1637 | §103 | Non-Final OA | 15d | Pending | Aug 03, 2023 |
| 18359250 | Dosing Regime For Treatment of Chronic Hand Eczema | BREDEFELD, RACHAEL EVA | 3786 | §103 | Non-Final OA | 110d overdue | Pending | Jul 26, 2023 |
| 18350986 | CELLS AND METHOD OF CELL CULTURE | HUMPHRIES, NICHOLAS ADAM | 1631 | §103 | Non-Final OA | 60d overdue | Pending | Jul 12, 2023 |
| 18347698 | SELF-AMPLIFYING RNA ENCODING AN INFLUENZA VIRUS ANTIGEN | CHEN, STACY BROWN | 1672 | Other | Non-Final OA | 8d overdue | Pending | Jul 06, 2023 |
| 18255868 | METHODS FOR PURIFICATION OF AAV VECTORS BY AFFINITY CHROMATOGRAPHY | TINSLEY, BRENDAN THOMAS | 1634 | §112 | Non-Final OA | 37d overdue | Pending | Jun 04, 2023 |
| 18255869 | METHODS AND COMPOSITIONS FOR INHIBITING EXCESS NUCLEIC ACID PRECIPITATION | TSAY, MARSHA M | 1656 | §103 | Non-Final OA | 2d overdue | Pending | Jun 04, 2023 |
| 18322395 | PURIFICATION OF ANTIBODY DRUG CONJUGATES USING A SODIUM PHOSPHATE GRADIENT | GAMETT, DANIEL C | 1647 | §103 | Non-Final OA | 17d overdue | Pending | May 23, 2023 |
| 18036141 | TALAZOPARIB SOFT GELATIN CAPSULE DOSAGE FORM | MERCIER, MELISSA S | 1615 | §103 | Final Rejection | 23d | Pending | May 09, 2023 |
| 18252124 | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | OGUNBIYI, OLUWATOSIN A | 1645 | Other | Non-Final OA | 13d | Pending | May 08, 2023 |
| 18034239 | IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES | MORGAN, BAILEY MICHELLE | 1645 | §103 | Non-Final OA | 216d overdue | Pending | Apr 27, 2023 |
| 18250570 | CRYSTAL-FREE HIGH-CONCENTRATION TESTOSTERONE CYPIONATE FORMULATIONS | MITCHELL, EDWIN COLEMAN | 1619 | §103 | Final Rejection | 26d overdue | Pending | Apr 26, 2023 |
| 18250252 | Methods for Purification of AAV Vectors by Anion Exchange Chromatography | ALAM, DANYAL HASSAN | 1672 | §103 | Non-Final OA | 84d overdue | Pending | Apr 24, 2023 |
| 18249411 | Methods for purifying bacterial polysaccharides | PATEL, PRANAV N | 1777 | §103 | Non-Final OA | 29d | Pending | Apr 18, 2023 |
| 18025879 | METHODS, THERAPIES AND USES FOR TREATING CANCER | HOLTZMAN, KATHERINE ANN | 1646 | Other | Non-Final OA | 114d overdue | Pending | Mar 10, 2023 |
| 18024245 | STREAMLINED ASSAY PREPARATION | YOUNG, NATASHA E | 1774 | §103 | Non-Final OA | 1d overdue | Pending | Mar 01, 2023 |
| 18006800 | IMPROVEMENTS TO WASH SOLUTIONS FOR ANION EXCHANGE CHROMATOGRAPHY IN A METHOD OF PURIFICATION OF RECOMBINANTLY-PRODUCED RSV PROTEINS | IANNUZO, NATALIE NMN | 1653 | §103 | Non-Final OA | 50d overdue | Pending | Jan 25, 2023 |
| 18004109 | Preparation Of A Pyrimidinyl-3,8-Diazabicyclo[3.2.1]Octanylmethanone Derivative And Salt Thereof | MOORE, SUSANNA | 1624 | Other | Non-Final OA | 36d overdue | Pending | Jan 03, 2023 |
| 18146014 | COMBINATION OF AN ANTI-PD-L1 ANTIBODY AND A DNA-PK INHIBITOR FOR THE TREATMENT OF CANCER | JOHANSEN, PETER N. | 1644 | Other | Final Rejection | 85d overdue | Pending | Dec 23, 2022 |
| 17924975 | METHODS, THERAPIES AND USES FOR TREATING CANCER | DENT, ALANA HARRIS | 1643 | Other | Final Rejection | 100d overdue | Pending | Nov 11, 2022 |
| 17997312 | MODIFIED NUCLEIC ACIDS ENCODING ASPARTOACYLASE (ASPA) AND VECTOR FOR GENE THERAPY | ALLEN, SARAH ELIZABETH | 1637 | Other | Non-Final OA | 34d | Pending | Oct 27, 2022 |
| 17997091 | PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES | WILLIS, DOUGLAS M | 1624 | §112 | Non-Final OA | 36d overdue | Pending | Oct 25, 2022 |
| 17837891 | COMPOSITIONS AND METHODS FOR TREATMENT OF ABNORMAL CELL GROWTH | PEEBLES, KATHERINE | 1617 | Other | Non-Final OA | 126d overdue | Pending | Jun 10, 2022 |
| 17431462 | Methods for purifying bacterial polysaccharides | CREWS, JARET JAMES | 1691 | Other | Non-Final OA | 53d overdue | Pending | Aug 17, 2021 |
| 17125555 | STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDES AND CONJUGATES THEREOF | LYONS, MARY M | 1645 | §112 | Final Rejection | 23d overdue | Pending | Dec 17, 2020 |
| 16978354 | ANTI-PD-1 ANTIBODY COMPOSITIONS | ALSOMAIRY, SARAH ABDOALATIF | 1646 | §103 | Final Rejection | 30d overdue | Pending | Sep 04, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial